Modulation of Subthalamic Low Beta and Finely Tuned Gamma Activity with Parkinson’s Therapy: Placebo Control Single-blind Study (S32.003)
To investigate the deep brain stimulation (DBS), levodopa, and placebo on subthalamic nucleus (STN) physiology and clinical symptoms in patients with Parkinson’s disease (PD).
Authors
- Coralie de Hemptinne (ORCID: https://orcid.org/0000-0003-2780-3666)
- Nobutaka Hattori (ORCID: https://orcid.org/0000-0002-2034-2556)
- Genko Oyama (ORCID: https://orcid.org/0000-0001-7985-5367)
- Hikaru Kamo (ORCID: https://orcid.org/0000-0002-9408-7893)
- Kara A. Johnson (ORCID: https://orcid.org/0000-0001-6556-8957)
- Hirokazu Iwamuro (ORCID: https://orcid.org/0000-0002-9970-6331)
- Jackson N. Cagle (ORCID: https://orcid.org/0000-0002-1955-8050)
- Joshua K. Wong (ORCID: https://orcid.org/0000-0002-4632-3417)
- Atsushi Umemura (ORCID: https://orcid.org/0000-0003-3229-4691)
Institutions
- University of Florida (US)
- Juntendo University (JP)
- Florida College (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212199
- Primary Topic
- Conducting polymers and applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00